Bitcoin (btc)$74,955.00↓ 0.06%
Ethereum (eth)$2,124.63↓ 0.63%
Tether (usdt)$0.999061↓ 0.01%
BNB (bnb)$689.13↑ 0.40%
USDC (usdc)$0.999513↑ 0.00%
XRP (xrp)$1.099↓ 1.86%
Solana (sol)$86.41↓ 0.75%
TRON (trx)$0.317577↓ 0.43%
Figure Heloc (figr_heloc)$1.04↑ 0.00%
Zcash (zec)$1,169.71↓ 4.74%
Hyperliquid (hype)$74.73↓ 0.19%
Monero (xmr)$582.92↓ 3.02%
Dogecoin (doge)$0.069829↑ 0.75%
USDS (usds)$1.00↑ 0.01%
LEO Token (leo)$9.33↑ 0.60%
Bitcoin (btc)$74,955.00↓ 0.06%
Ethereum (eth)$2,124.63↓ 0.63%
Tether (usdt)$0.999061↓ 0.01%
BNB (bnb)$689.13↑ 0.40%
USDC (usdc)$0.999513↑ 0.00%
XRP (xrp)$1.099↓ 1.86%
Solana (sol)$86.41↓ 0.75%
TRON (trx)$0.317577↓ 0.43%
Figure Heloc (figr_heloc)$1.04↑ 0.00%
Zcash (zec)$1,169.71↓ 4.74%
Hyperliquid (hype)$74.73↓ 0.19%
Monero (xmr)$582.92↓ 3.02%
Dogecoin (doge)$0.069829↑ 0.75%
USDS (usds)$1.00↑ 0.01%
LEO Token (leo)$9.33↑ 0.60%

Beiersdorf Partners with Vincere Biosciences to Develop Cell-Rejuvenating Skincare – Draper Decentralized – 6.04.25

Published June 4, 2025

Beiersdorf has entered a strategic partnership with Cambridge-based Vincere Biosciences to co-develop skincare solutions targeting cellular aging. The collaboration focuses on mitophagy, combining Beiersdorf’s expertise in coenzyme Q10 with Vincere’s research on the USP30 enzyme.